Targeting PDGFRb for superior bladder cancer treatment (SITC 2023)
Moreover, in our BC patients’ cohort and cell lines, we found a downregulation of miR-138–5p expression along with tumor progression, suggesting a negative regulation of the PDGFb/PDGFRb by miR138–5p. Conclusions Our preliminary results reveal the role of PDGFb/PDGFRb in maintaining tumor cells fitness and highlight a molecular loop involving PDGFRb and miR-138–5p in BC, that might represent not only a useful biomarker for improved diagnosis and patients’ stratification, but also as a promising axis that can be therapeutically targeted in situ.